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INTRODUCTION
Gastro-Esophageal Reflux Disease (GERD) is a
pathological condition of esophagus which is caused
by gastric content reflux into esophagus. The typical
symptom is burning sensation in chest area, but it can
also come with other symptoms such as regurgitation
(sour and bitter taste in tongue), epigastric pain,
dysphagia or odinophagia.1
The prevalence of gastro-esophageal reflux
disease is quite high. In western countries, the
prevalence is 10-20%, but in Asia the prevalence is
only 3-5%, except in Japan 13-15% and in Taiwan
approximately 15%.2 In 1998, Syafruddin reported a
study  in patients with dyspeptic symptoms who
underwent endoscopy in Cipto Mangunkusumo
hospital; esophagitis was found in 22.8% of them.3
Syam et al reported that among 1,718 patients in Cipto
The Role of Esophageal pH-metri Test on
Gastro-Esophageal Reflux Disease Diagnosis
Katharina Setyawati*, Murdani Abdullah**, Ari Fahrial Syam**,
Achmad Fauzi**, Dadang Makmun**, Marcellus Simadibrata**,
Chudahman Manan**, Abdul Aziz Rani**
* Department of Internal Medicine, Faculty of Medicine, University of Indonesia/
Dr. Cipto Mangunkusumo General National Hospital, Jakarta
** Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine
University of Indonesia/Dr. Cipto Mangunkusumo General National Hospital, Jakarta
ABSTRACT
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who are being suspected for abnormal esophageal reflux; evaluating patients with normal endoscopic
result but still having refractory reflux symptoms against proton pump inhibitor medication; detecting
refractory reflux in patients chest pain following the heart evaluation; evaluating patients with
otolaryngologic manifestations (laryngitis, pharyngitis, chronic cough) of the esophageal reflux disease
after therapeutic failure of 4-weeks proton pump inhibitor treatment; and looking for correlation
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Mangunkusumo Hospital who underwent upper
gastrointestinal tract endoscopy based on dyspepsia
indication in 5 year time (1997-2002), there was an
increase in esophagistis prevalence from 5.7 in 1997
into 25.18% in 2002 (mean 13.13%). In the United
States, the prevalence of gastro-esophageal reflux
disease increases significantly, almost 25% of
population experiences GERD.4
Gastro-esophageal reflux disease is by with
esophagitis appearance with or without mucosal break.
Confirmed diagnosis of esophagitis reflux disease is
established by histopathological examination of
esophageal tissue.1 Upper gastro-intestinal tract
endoscopy has low sensitivity in diagnosing GERD.
Abnormal esophageal mucosa is not found in
approximately 50% patients who undergo endoscopy.
Endoscopy is the gold standard for diagnosing erosive
esophagitis, Barrett’s esophagus, esophageal stricture
and adenocarcinoma.5 Twenty-four-hour esophageal
pH monitoring test is the gold standard diagnostic test
to assess gastric acid reflux into esophagus.7-10
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DEFINITION
Gastro-esophageal reflux disease is a pathological
condition which is caused by gastric content reflux
through incompetent gastro-esophageal junction
causing trauma and inflammation on esophageal
mucosa. Gastro-esophageal reflux disease can be
categorized into three distinct groups, which are Non-
Erosive Reflux Disease (NERD), erosive esophagitis
and Barrett’s esophagus. NERD is defined with the
presence of typical symptoms of gastro-esophageal
reflux disease which is caused by intra-esophageal
gastric content but no abnormal esophageal mucosa is
not found on endoscopy.5,6
International workshop group (World Congress of
Gastroenterology in Los Angeles 1994) stated the
presence of mucosal break as a diagnosis of erosive
esophagitis. It also categorized the degree of
esophagitis into four stages according to the extent of
esophagitis (table 1).5,11
different length which can be recognized during
endoscopy and is confirmed by intestinal metaplasia,
which is found inn esophageal biopsy result.5
PATHOGENESIS
Esophagitis on GERD will occur if there is a
contact between refluxate material and esophageal
mucosa for long period of time, also if there is a
decrease in mucosal resistance or esophageal tissue
protection setting off trauma and inflammation on
esophageal mucosa which will cause GERD signs and
symptoms to appear. Thus, it can be stated that
pathogenesis of GERD associates with the imbalance
between defensive factors of esophageal mucosa and
aggressive factors of refluxate material which are
originated from stomach, where there is shortcoming
in defensive factor compared to its aggressive factor.11-13
GERD occur due to various factors, e.g. because
of:3,6,11-14 (1) Incompetent Lower Esophageal
Sphincter (LES). LES can be caused by hiatus hernia,
LES total length, drugs (anti-cholinergic, beta
adrenergic antagonist, theophylline, benzodiazepine,
calcium channel blocker, opiates), hormonal factors
(pregnancy, elevated progesterone, cholecystokinine,
secretine level); (2) Transient Lower Esophageal
Sphincter Relaxation (TLESR). There is spontaneous
LES relaxation which lasts for 5 seconds without
preceding swallowing process. GERD with normal LES
is mostly caused by transient LES relaxation; (3)
Decreased or delayed acid clearance from
esophagus. There are 4 types of clearance process
from normal esophagus including gravitational force,
peristaltic force, salivation and formation of intrinsic
bicarbonate by esophagus. Night time reflux cannot
be overcome because the absence of gravitational force
and saliva, and the peristaltic process does not
According to the recent guideline from American
College of Gastroenterology, Barrett’s esophagus is
defined as esophageal epithelial alteration with
Figure 1. Symptoms and complication of gastro-esophageal reflux disease.18
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Table 1. Los Angeles Classification on the degree of 
esophagitis.5,11 
Damage degree Endoscopic features 
A Small erosion on esophageal mucosa 
with diameter <  5 mm 
B Erosion on esophageal mucosa /fold with 
diameter > 5 mm which are not 
connected to one another 
C Confluent lesions which are not in 
contact/encircling the whole lumen            
(< 75%) 
 Esophageal mucosa lesion which 
encircles at least 75% of the whole 
lumen (encircling the whole esophageal 
lumen) 
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function; (4) Gastric abnormality which increases
physiological reflux, e.g. gastric dilatation, pylorus
obstruction and delayed gastric emptying; (5)
Decreased epithelial mucosa resistance; (6) Chemical
composition of refluxate fluid, whether it is only
composed of gastric acid, pepsin or duodenal/biliary
fluid. Certain food, such as lime juice, tomatoes and
coffee, increases the symptoms of GERD patients.
Patients usually complain of epigastric, retrosternal
or lower chest discomfort. Such discomfort commonly
manifest into heartburn, dysphagia, nausea or
regurgitation. Patients sometime have complaints of
sour or bitter taste on tongue or hyper-salivation. Heart-
burn sensation can sometime be found in healthy
persons; however, if it happens every day and repeat-
edly, it has diagnostic prediction value of 60%. Heart-
burn predominantly occurs at night or after meal. This
complaint becomes exaggerated during bending posi-
tion or after consuming alcoholic beverage, fruit juice,
coffee, and hot or cold beverage. This disease can cause
several complications, such as stricture (10%),
bleeding (rare), Barrett’s esophagus (12.4%),
esophageal cancer or esophagus adenocarcinoma
(10%). In addition to esophageal abnormality, extra-
esophageal complications may occur, such as
laryngitis, bronchitis, bronchiectasis or asthma.12,13,15-19
DIAGNOSIS
Technical Aspect of Esophageal pH-metryTest
Basic equipments for esophageal pH-metry test are
portable data loggers, pH electrode, computer and
software to analyze pH data.20 Electrode is inserted
through the nostril down to 5 cm above the upper rim
of Lower Esophageal Sphincter (LES). This 5 cm length
is to prevent electrode displacement into the stomach
when esophagus contract during swallowing process.
Extremely high electrode placement above LES may
decrease this test sensitivity.20,21
Original evaluation system according to Johnson and
DeMeester evaluates 6 variables, i.e: (1) total
percentage of time when pH < 4 (normal < 4.2);
(2) pH percentage < 4 during standing position
(normal < 6.3); (3) pH  percentage < 4 during prone
position (normal < 1.2); (4) the number of reflux
episode (normal < 50); (5) the number of reflux
episode with pH < 4 for ≥ 5 minutes (normal three
times or less); (6) the longest single acid exposure
episode period (normal 9.2). 10,20,22  According to
consensus total percentage of time of pH < 4 (the
period of acid exposure on esophagus) is the most
distinguishing factor between physiological and
pathological reflux.20
Interpretation Technique and Normal Value of
Esophageal pH-metry
Esophageal reflux is a physiological phenomenon
in normal individual. The aim of esophageal pH
monitoring is to identify patients with GERD by
demonstrating reflux pathologic degree. Besides being
influenced by acid exposure period in patients with
GERD, the factors that can differentiate GERD
patient from control are acid sensitivity of esophageal
mucosa, mucosal resistance to inflammation, the
extent of mucosa exposed to acid, or the composition
of refluxate fluid other than acid.
Acid Exposure on Esophagus in Normal Control
versus Esophagitis
In accordance with a study shown on table 2,
comparing acid exposure period on esophagus in
normal persons and esophagitis patients, sensitivity of
77-100% and specificity of 85-100% are found.
Although table 2 only shows pH < 4 percentage data,
but other parameters show similar result.20
Acid Exposure on Esophagus in Normal Control
versus GERD patients with negative Gastro-
Duodenal Endoscopy
Heartburn and acid regurgitation are typical reflux
symptoms which occur in 40% normal population have
not received treatment. According to studies on table
3, the “normal” criteria being used on pH monitoring
data analysis varies among studies. Subjects with
negative endoscopy result show that the mean value
of acid exposure is slightly above normal.20
Table 2. Acid exposure on esophagus in patients with esophagitis20,22,23 
Reference 
Control  Patient with esophagitis 
Sensitivity and specificity Upper limit of 
normal percent  
pH < 4 
n 
Range of mean age 
(year)  
Mean percent 
pH < 4 
Vitale et al 7.2 35 51 (20-82) 9.6 77% and 91% 
Schindlbeck et al 7.0 16 47 (18-73) 18.8 89% and 93% 
Johnssson et al 3.4 20 51 (28-74) Not stated 87% and 97% 
Mattioli et al 5.0 11 48 (21-78) 29.8 100% and 100% (grade 2) 
  37  27.6 92% and 100%  
(grade 3) 
Masclee et al 4 44 48 12.6 91% and 85% 
Kapasidis et al 3.9 21 37 31.7 Not provided 
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Reflux-symptoms Correlation 
In accordance with facts, a significant reflux event  
may cause atypical symptom (chest pain); therefore,  
24-hour-pH data analysis associated with symptoms is  
carried out to the patients by marking the events. To  
determine a significant pain-reflux association, we can  
use:20,21 (1) Symptom Index (SI): is defined as the  
number of symptoms episode associated with reflux  
(pH < 4) divided by the number of symptoms episode  
(in percentage). This formula has limitation of not  
being able to calculate the number of total reflux  
episode; (2) Symptom Sensitivity Index (SSI): is a  
percentage of symptoms correlated to reflux episode  
divided by the number of total reflux episode. This  
system is also limited and incapable to calculate the  
number of total symptom episode; (3) Symptom  
Association Probability (SAP): is calculated by using  
contingency table which comprises of four parts: (a)  
positive symptom, positive reflux: (b) negative  
symptom, positive reflux; (c) positive symptom,  
negative reflux; and (d) negative symptom, negative  
reflux. Fisher’s exact test is used to calculate  
probability of correlation between reflux and symptom  
occurrence. SAP value > 95% indicates that the  
probability of correlation between reflux and symptom  
by chance is < 5%. 
 
CLINICAL APPLICATION 
The Application of 24-hour Esophageal pH-metri 
The 24-hour esophageal pH-metry is very  
beneficial in diagnosing and managing patients with  
esophageal syndrome, including gastro-esophageal  
reflux, extra-esophageal manifestation or chest pain.  
The roles of 24 hour esophageal pH-metry are: (1) to  
look for abnormal acid exposure on esophagus, which  
has no abnormality found on endoscopy, (2) to  
evaluate patients following the anti-reflux surgery who  
are being suspected to have abnormal esophageal  
reflux, (3) to evaluate patients with normal endoscopic  
result but still having refractory reflux symptoms against  
proton pump inhibitor medication; (4) to detect  
refractory reflux in patients with chest pain following  
the heart evaluation; (5) to evaluate patients with  
otolaryngologic manifestations (laryngitis, pharyngitis,  
chronic cough) of esophageal reflux disease after 
therapeutic failure of 4-week proton pump inhibitor 
treatment; (6) to look for the correlation between adult 
onset gastro-esophageal reflux disease and non- 
allergic asthma.20 
Typical Gastro-esophageal Reflux Disease 
Reflux test is generally not indicated for the 
majority of GERD patients with noticeable improving 
symptoms due to medical treatment. Patients with 
reflux complication, such as erosive esophagitis, 
peptic stricture or Barrett’s esophagus, do not need 
pH test to confirm the diagnosis. The first indication is 
to document abnormal acid reflux prior to surgical 
treatment or GERD endoscopy or for GERD 
treatment research purpose.20,21,24 
Several studies show that esophageal pH test is 
more sensitive in patients with erosive esophagitis 
compared to non-erosive reflux. The severity of 
erosive esophagitis has positive correlation with acid 
exposure on distal esophagus.25-27 
The second indication in GERD patients is to  
monitor adequate reflux control following medical treat- 
ment in asymptomatic patients with complication. High  
degree of acid exposure on distal esophagus is  
correlated to the length part of Barrett’s esophagus.  
Some studies prove that patients with Barrett’s  
esophagus fail to normalize acid on distal esophagus  
even they are being under PPI treatment. In this  
particular case, there is a confounder. Patients with  
Barrett’s esophagus have decreased sensitivity to acid  
reflux events, thus they do not realize reflux  
occurence.28 
Refractory Chest Pain 
Esophageal pH monitoring is generally used to  
evaluate patients with persistent reflux symptoms,  
regardless of having received therapy or surgery. In  
these patients, several tests are being done, including  
pH monitoring, biliary reflux detection, or impedance  
monitoring to differentiate reflux symptom associated  
with inadequate GERD treatment or its etiology is not  
associated with GERD. In such case, endoscopic  
detection on distal erosive esophagitis is not specific  
and not sensitive.21,29 
Refractory heartburn is defined as heartburn which  
is irresponsive to acid suppression therapy. Although  
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Table 3. Acid exposure on esophagus in GERD patients with negative endoscopy result.20,22,23 
Reference 
Upper limit of normal 
percent  
pH < 4 
Patient with GERD Sensitivity and 
specificity n Mean percent  pH < 4 
Vitale et al 7.2 11 5.8 64% and 91% 
Schindlbeck et al 7.0 29 10.2 Not  provided 
Mattioli et al 5.0 6 1.9 0% and 100% (grade 0) 
32 13.6 71% and 100% (grade 1) 
Masclee et al 4 23 6.4 61% and 85% 
Kapasidis et al 3.9 21 11.6 Not provided 
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PPI therapy is perceived as the best therapeutic agent
up to now, but the dose and time of PPI therapy on
failure cases has not been studied. There is significant
abnormal acid exposure in patients with severe
erosive esophagitis degree, although they have been
treated with PPI therapy.21
There are three common points that need to be
observed by using pH test in  patients with refractory
reflux symptom who are under treatment, i.e.: (1)
Abnormal acid exposure on esophagus frequently
occurs in patients who have once daily PPI therapy
with typical and atypical reflux symptom; (2) Patients
with greater reflux complication - including greater
esophagitis severity degree and Barrett’s esophagitis
– have lower pH normalization regardless of twice daily
PPI therapy; (3) Diagnosis with pH test in refractory
patients yields more representative result in patients
with typical reflux symptom than in patients with
extra-esophageal symptom. 21
Chronic Laryngeal Symptom
Patients with dominant symptoms such as chronic
cough, hoarse voice, globus, sore throat and excessive
throat clearing are often diagnosed as GERD after
laryngoscopy procedure. Twenty-four-hour pH
monitoring is frequently performed following
endoscopy if esophagitis is not found. Prevalence prior
to therapy in abnormal pH test is reported to be 53%,
with acid exposure prevalence on distal, proximal and
hypo-pharynx of 42%, 44% and 38%, respectively.21
As in non-cardiac chest pain, practical and popular
approach is by means of empirical test with twice daily
PPI regimen for several months; pH test is reserved
for patients with persistent symptom. Application of
pH test result is limited in clinical setting. Charbel et al
reported that out of 115 patients with extra-esophageal
symptom who have twice daily PPI regimen,
abnormal acid reflux result was only found in 1% of
them.30
Chest Pain
Approximately 30% patients with recurrent chest
pain have normal coronary arteriography. Chest pain
associates with GERD, which is similar to angina
pectoris symptom. Abnormal esophageal pH is found
in approximately 60% patients with non-cardiac chest
pain, either in the form of both abnormal acid exposure
and/or associated with reflux symptom.20,21,24
Empirical test with high-dose PPI is one of
options for diagnosing GERD in patients with non-
cardiac chest pain. Twenty-four-hour pH monitoring
is performed if patients do not respond to high-dose
PPI. Acid reflux can be excluded as the cause of
non-cardiac chest pain in patients with recurrent chest
pain episode - regardless whether they are having
therapy or not -and in patients with normal pH test
result. pH analysis has to be combined with reflux
symptom correlation calculation for patients with chest
pain symptom and persistent reflux on PPI
therapy.13,20,21
Extra-esophageal symptoms on GERD
Double dose PPI therapy for 3-6 months
or
PPI trial therapy for 2 weeks
24 hour esophageal
pH-metri test
FailSuccessful
Lowered PPI dose
Figure 4. Evaluation for GERD patients with extra-esophageal
symptom.19
Figure 3. Algorithm of management for patients with non-cardiac
chest pain.19
Non-cardiac chest pain
Alarm symptoms (weight loss, dysphagia,
anorexia, hematemesis)
Trial therapy
using PPI Upper GI tract Endoscopy
(-)
(+)
Therapy for abnormal
mucosa
(-)
GERD therapy
(double dose of PPI)
24-hour esophageal pH-
metri
(+)
(-)
Upper GI tract endoscopy
PH-
Asthma
GERD prevalence in asthmatic patient ranges from
34% to 89%. Abnormal acid reflux result is often found
in asthmatic patients without reflux symptom (silent
refluxers). The role of esophageal pH monitoring is
Figure 2. Algorithm of refractory GERD evaluation.29
GERD symptoms (+)
The presence of esophagitis is unknown
Does not improve
Single dose PPI treatment
Refractory GERD
Assess compliance
Therapy dose (double PPI dose)
Substitute with different PPI
Esophagitis (-)
Upper GI Tract Endoscopy
Esophageal pH-metri
Esophagitis (+)
 tract endosc py
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still unknown in asthmatic patients. Although
according to latest study, abnormal pH test prevalence
reaches 66%, this test cannot determine whether this
acid reflux causes asthma or GERD induces asthma
attack.31
As in patients with extraesophageal symptom, most
patients with suspected asthma on GERD do not need
preliminary esophageal pH test. Acid suppression
empiric test with double dose of PPI treatment
followed with 24-hour pH monitoring in irresponsive
patients is the most cost-effective diagnostic test to
determine GERD that aggravates asthma.32
CONCLUSION
Gastro-esophageal reflux disease is a pathological
condition on esophagus which is caused by gastric
content reflux into esophagus. There is increased
prevalence of gastro-esophageal reflux. Esophagitis on
GERD occurs if there is a contact between refluxate
material and esophageal mucosa for long period of time,
also if there is a decrease in mucosal resistance or
esophageal tissue protection setting off trauma and
inflammation on esophageal mucosa.
Esophageal pH monitoring is indicated to look for
acid exposure on abnormal esophagus with no
abnormality found in endoscopy, to evaluate patients
following the antireflux surgery who are being s
uspected for abnormal esophageal reflux, to evaluate
patients with normal endoscopic result but still having
refractory reflux symptoms against proton pump
inhibitor medication, to detect refractory reflux in
patients with chest pain following the heart evaluation,
to evaluate patients with otolaryngologic manifestations
(laryngitis, pharyngitis, chronic cough) of esophageal
reflux disease after therapeutic failure of 4-week
proton pump inhibitor treatment, to look for the
correlation between adult onset gastro-esophageal
reflux disease and non-allergic asthma.
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